3ln2
From Proteopedia
(Difference between revisions)
m (Protected "3ln2" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:3ln2. | + | [[Image:3ln2.png|left|200px]] |
<!-- | <!-- | ||
| Line 11: | Line 11: | ||
===Crystal Structure of a Charge Engineered Human Lysozyme Variant=== | ===Crystal Structure of a Charge Engineered Human Lysozyme Variant=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21408218}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21408218 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21408218}} | ||
==About this Structure== | ==About this Structure== | ||
[[3ln2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3LN2 OCA]. | [[3ln2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3LN2 OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:21408218</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Gill, A.]] | [[Category: Gill, A.]] | ||
[[Category: Griswold, K E.]] | [[Category: Griswold, K E.]] | ||
| - | [[Category: Scanlon, T | + | [[Category: Scanlon, T C.]] |
Revision as of 06:26, 23 March 2011
Crystal Structure of a Charge Engineered Human Lysozyme Variant
Template:ABSTRACT PUBMED 21408218
About this Structure
3ln2 is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Gill A, Scanlon TC, Osipovitch DC, Madden DR, Griswold KE. Crystal structure of a charge engineered human lysozyme having enhanced bactericidal activity. PLoS One. 2011 Mar 7;6(3):e16788. PMID:21408218 doi:10.1371/journal.pone.0016788
